Regression of an ALK-Negative Cerebral Inflammatory Myofibroblastic Tumour by Steroid Therapy: A Case Report and Literature Review
Journal of Cancer Biomoleculars and Therapeutics · 2024
DOI: 10.62382/jcbt.v1i1.5 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cancer Biomoleculars and Therapeutics, 2024. Verfasst von Yijun Ge und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Inflammatory myofibroblastic tumours (IMTs) are non-neoplastic lesions characterized by collagenous stroma and polyclonal mononuclear infiltrates. IMTs typically arise in the lung, retroperitoneum or abdominal region but rarely in the central nervous system (CNS). The primary therapeutic option is surgical resection, and other therapies are currently controversial. Case report: We report a case of 23-year-old male ALK-negative cerebral IMT patient from Han population via steroid therapy. No relapse is observed at the follow-up visit.
Conclusion
These results support the role of internal medication and promote the use of personalized therapy in genome-profiled IMTs.
Zitieren
APA
Ge, Y., Wu, L., Xie, C., Da, Q., & Dai, Y. (2024). Regression of an ALK-Negative Cerebral Inflammatory Myofibroblastic Tumour by Steroid Therapy: A Case Report and Literature Review. Journal of Cancer Biomoleculars and Therapeutics. https://doi.org/10.62382/jcbt.v1i1.5
Vancouver
Ge Y, Wu L, Xie C, Da Q, Dai Y. Regression of an ALK-Negative Cerebral Inflammatory Myofibroblastic Tumour by Steroid Therapy: A Case Report and Literature Review. Journal of Cancer Biomoleculars and Therapeutics. 2024. doi:10.62382/jcbt.v1i1.5
BibTeX
@article{Ge2024,
author = {Ge, Yijun and Wu, Lili and Xie, Chengjuan and Da, Qian and Dai, Ying},
title = {Regression of an ALK-Negative Cerebral Inflammatory Myofibroblastic Tumour by Steroid Therapy: A Case Report and Literature Review},
journal = {Journal of Cancer Biomoleculars and Therapeutics},
year = {2024},
doi = {10.62382/jcbt.v1i1.5}
}
EUVIMED